Association between gout and cancers: A systematic review and meta-analysis
Lin Tian,Youjiao Wang,Ying Zhang,Lv Tian,Huijing Wang
DOI: https://doi.org/10.1097/md.0000000000040234
IF: 1.6
2024-10-30
Medicine
Abstract:Gout is a metabolic, immune disease characterized by disturbances in purine and uric acid metabolism. In adults, gout is one of the most common forms of inflammatory arthritis, affecting approximately 9.2 million adults in the United States (3.9% prevalence) [ 1 ] and 41.2 million adults worldwide. [ 2 ] Gout is caused by the supersaturation of uric acid, which crystallizes within the joints, leading to peripheral joint synovitis and severe pain. [ 3 , 4 ] As the number of acute attacks of gout increases, patients progress to joint damage, deformities, chronic pain, subcutaneous uric acid crystal deposits, and kidney damage. There is a clear association between gout and the metabolic syndrome. [ 5 , 6 ] The prevalence of components of the metabolic syndrome that are associated with gout or hyperuricemia include hypertension, [ 6 , 7 ] insulin resistance/diabetes mellitus, [ 7 , 8 ] obesity, [ 6 , 8 ] and dyslipidemia. [ 6 ] The high prevalence of the metabolic syndrome and its components likely contributes to the higher risk of cardiovascular disease, [ 7 , 8 ] emergencies, [ 8 , 9 ] and death in gout patients. [ 10 ] The development of gout is often based on long-term metabolic disturbances. There is increasing interest in the relevance of metabolism and immunity in the pathogenesis of gout, and it has been hypothesized that the metabolic syndrome is associated with carcinogenesis. [ 5 , 11 ] In recent years, widespread interest has arisen in the association between gout, hyperuricemia, and cancer. High cellular metabolism may lead to hyperuricemia and tumorigenesis, implying a potential link between disturbances in purine metabolism and cancer. [ 12 ] A large body of literature has shown an association between high serum uric acid levels and an independent increase in the risk of cancer. [ 13–15 ] In addition, the massive lysis of malignant cells in certain patients with tumor lysis syndrome leads to hyperuricemia, which in turn predisposes to renal failure, coronary heart disease, and gout. [ 16 , 17 ] Interestingly, because of its systemic antioxidant properties, uric acid has been hypothesized to have a protective role in carcinogenesis. [ 18 ] However, the association between gout and tumor risk remains controversial. Recent epidemiologic studies have presented conflicting results on the association between gout and cancer risk. [ 12 , 19–23 ] Given these conflicting reports, we conducted a meta-analysis to elucidate cancer risk in patients with gout.
medicine, general & internal